Pharmafile Logo
Pharmafocus logo
Advanced Search

WHO

Showing 15 posts of 103 posts found.

cholera_infection_map

Global campaign to reduce cholera deaths by 90%

October 4, 2017
Medical Communications, Research and Development Cholera, WHO, biotech, drugs, pharma, pharmaceutical

A new campaign, launched by the WHO, has begun today to reduce deaths from cholera by 90% through to 2030. …

News

Measles eradicated in the UK, according to WHO

September 28, 2017
Medical Communications UK, WHO, biotech, drugs, measles, pharma, pharmaceutical

The measles virus has been eliminated from the UK for the first time in the country’s history, according to the …

News
world_health_organization

Antibiotic development is inadequate to meet global resistance threat, WHO warns

September 20, 2017
Research and Development WHO, antibiotic resistance, antimicrobial resistance, pharma, pharmaceutical, world health organization

The World Health Organization (WHO) has released a report indicating that worldwide development of new antibiotics is not keeping pace …

News
vaccine

Hope in quest for gonorrhoea vaccination

July 11, 2017
Manufacturing and Production, Research and Development WHO, gonorrhoea, meningitis, vaccination

Only last week, the WHO expressed serious concerns about the possibility of strains of gonorrhoea developing that could be resistant …

News
vaccination-1215279_960_720

Bhutan and Maldives successfully eliminate measles

June 14, 2017
Medical Communications, Research and Development WHO, immunisation, measles, rubella

The WHO has announced that Bhutan and Maldives have become the first South-East Asia region countries to successfully eliminate measles. …

News
dr

WHO elects first African Director General

May 26, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, appointment

Ethiopian-born Tedros Adhanom Ghebreyesus has been announced as the Next Director General of the World Health Organization (WHO) after securing …

Appointment
dr

Tedros Adhanom Ghebreyesus becomes WHO Director General

May 25, 2017
Medical Communications WHO

Ethiopian-born Tedros Adhanom Ghebreyesus has been announced as the Next Director General of the World Health Organization (WHO) after securing …

News
world_health_organization_flag

WHO aims to increase uptake of biosimilars in poorer countries

May 4, 2017
Medical Communications, Research and Development Cancer, Roche, WHO, biosimilars

The WHO has announced that it will launch a project to prequalify biosimilar medicines for the treatment of certain cancers. …

News
mental-health-2019924_640

Five crucial facts about mental health

April 24, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing WHO, anxiety, depression, mental health, world health day

7 April marked this year’s World Health Day, and for 2017 the WHO selected depression as the annual focus. Prevalent …

Feature
world_health_organization_flag

WHO releases list of bacteria that pose greatest threat to humankind

February 28, 2017
Research and Development WHO, antibiotic resistance

The World Health Organisation (WHO) has published a list of the 12 bacteria that are thought to present the largest …

News
immunisation

African Heads of State commit to universal access to immunisation

February 1, 2017
Medical Communications, Research and Development Africa, Vaccine, WHO, immunisation

The Heads of State convened from across Africa to ratify the Addis Declaration on Immunization (ADI). The pledge commits to …

News
3020361085_f37fb25e92_z

Male birth control injection has high efficacy but side-effects halt trials

October 28, 2016
Medical Communications WHO, birth control, male contraceptive, pregnancies

The study, funded by the World Health Organization, found a jab was close to 96% effective in tests to ascertain …

News
johnson_and_johnson_jj

Janssen’s New Drug Application for drug to treat intestinal worms gets US FDA priority review

July 14, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Johnson & Johnson, US FDA, WHO, drug trial, new drug application, regulation, soil-transmitted helminthiasis

Johnson & Johnson (NYSE: JNJ) said the US Food and Drug Administration (FDA) has granted Priority Review for its New …

News
test_results

FDA, WHO criticise integrity of data at contract research firm Semler

April 25, 2016
Research and Development, Sales and Marketing FDA, India, WHO, World Health Organisation, semler, semler research

The US Food and Drug Administration and the World Health Organisation have raised serious concerns related to violations of good …

News
GAVI logo

MSD and GAVI agree Ebola vaccine deal

January 20, 2016
Manufacturing and Production, Research and Development Ebola, GAVI, MSD, WHO

MSD and the global vaccine alliance Gavi have agreed a deal to provide 300,000 dosesof  an Ebola virus vaccine, to …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026